Cargando…
Circulating biomarkers in patients with glioblastoma
Gliomas are the most common tumours of the central nervous system and the most aggressive form is glioblastoma (GBM). Despite advances in treatment, patient survival remains low. GBM diagnosis typically relies on imaging techniques and postoperative pathological diagnosis; however, both procedures h...
Autores principales: | Müller Bark, Juliana, Kulasinghe, Arutha, Chua, Benjamin, Day, Bryan W., Punyadeera, Chamindie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000822/ https://www.ncbi.nlm.nih.gov/pubmed/31666668 http://dx.doi.org/10.1038/s41416-019-0603-6 |
Ejemplares similares
-
Isolation of Circulating Tumour Cells in Patients With Glioblastoma Using Spiral Microfluidic Technology – A Pilot Study
por: Müller Bark, Juliana, et al.
Publicado: (2021) -
Capture of Circulating Tumour Cell Clusters Using Straight Microfluidic Chips
por: Kulasinghe, Arutha, et al.
Publicado: (2019) -
The Use of Microfluidic Technology for Cancer Applications and Liquid Biopsy
por: Kulasinghe, Arutha, et al.
Publicado: (2018) -
Isolation of circulating tumor cells in non-small-cell-lung-cancer patients using a multi-flow microfluidic channel
por: Zhou, Jian, et al.
Publicado: (2019) -
PD-L1 expressing circulating tumour cells in head and neck cancers
por: Kulasinghe, Arutha, et al.
Publicado: (2017)